Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.98 USD | +0.04% | +0.07% | +240.94% |
May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
May. 09 | Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.94% | 4.46B | |
+8.48% | 114B | |
+10.69% | 104B | |
-12.65% | 22.41B | |
-0.58% | 22.28B | |
-5.80% | 19.07B | |
-37.36% | 18B | |
-5.27% | 17.89B | |
+7.54% | 14.28B | |
+36.34% | 12.55B |
- Stock Market
- Equities
- ALPN Stock
- News Alpine Immune Sciences, Inc.
- Alpine Immune Sciences Insider Sold Shares Worth $1,120,992, According to a Recent SEC Filing